In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AlphaRx > Message
Generic_profile

Re: new shareholder

Posted by: Tutty on November 06, 2006 03:43PM

In response to: new shareholder by skyhigh

hey skyhigh. welcome here. You're very right about this stock/company being undervalued. The potential for this to reach $1.00 is very likely. You got in at a good time. The company is due to release its results from its phase II clinical trials. Sit back, and hang tight. This is a good one :)
Did You Know?

The Front Page AGORACOM Blog is a great source of industry information for small cap investors

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote